ORYZON announces submission of Phase III protocol to FDA to initiate PORTICO-2 trial of v... 23/06/2025 Healthcare Access to innovation PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients. Partners - Oryzon Genomics
GENESIS Biomed participated in the valuation of CellsIA, a company acquired by Laboratorio... 19/06/2025 Healthcare Access to innovation GENESIS Biomed provides specialised services in the valuation and search for licensees or acquirers for biomedical... Partners - GENESIS Biomed
BeCytes opens new laboratory to accelerate the production of in vitro cellular models 19/06/2025 Healthcare Access to innovation BeCytes Biotechnologies, a company specialized in the research and development of in vitro cellular models, has launched... Partners - BeCytes Biotechnologies
Advanced Therapies Congress 2026 ExCeL, London United Kingdom Del 17/03/2026 to 18/03/2026 Access to innovation
Theriva™ Biologics Announces Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clini... 04/06/2025 Healthcare Access to innovation Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma... Partners - THERIVA BIOLOGICS S.L.
Genetics Becomes an Ally for Healthcare Professionals 03/06/2025 Healthcare Access to innovation Digitalization Personalized medicine is no longer a promise—it's a reality, with genetics as its key ally. To bring this knowledge into... Partners - ADNTRO GENETICS SL
BCN HEALTH publishes a study highlighting the substantial healthcare costs associated with... 03/06/2025 Healthcare Access to innovation BCN HEALTH has published the study ‘Hepatocellular carcinoma: what are the differential costs compared to the general... Partners - BCN Health
Accelerating molecular discovery using an in silico design platform 08/07/2025 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies Industrial biotechnology Join our free event on Tuesday, July 8th at the Parque Científico de Barcelona for an extended version of our Lunch and... Partners
Sodena leads BioSintNA, the Synthetic Biology Business Plan in Navarra 27/05/2025 Healthcare Access to innovation Navarre takes a strategic step toward the future with the launch of BioSintNA, an ambitious synthetic biology business... Partners - SODENA
